FDA would ban drugs tied to Chinese government

What does this do?

This bill would require the FDA to review drug applications and check whether the company behind them has financial or organizational ties to the Chinese government, Communist Party, or military. Companies found to have those ties would be blocked from getting drug approvals, and their already-approved drugs could be turned away and destroyed at the border. A company could avoid the ban if it proves it cut those ties or sells its drug licenses to an unrelated company within 180 days, and drugs could still enter if blocking them would cause a shortage.

Who does it affect?

This bill primarily affects pharmaceutical companies with ties to China and the U.S. agencies that handle drug approvals and border enforcement. American patients and pharmacies that rely on drugs made or owned by Chinese-linked companies could also be affected.

Why does it matter?

If passed, some drugs currently available in the United States could be blocked from entering the country or lose their approval status. Patients and pharmacies depending on those drugs could face reduced access, especially if a shortage exception does not apply.

Where does it stand?